Fundraising Fox
Leash Bio
Founded 2021 · 13 employees on LinkedIn · 2 known investors
Find your way into Leash Bio
Sign up to see every warm intro you have to Leash Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Leash Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Leash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.
Founders & leadership
Leash Bio was founded in 2021 by Ian Quigley and Andrew Blevins.
IQ
Ian QuigleyCEO, Co-founderIan Quigley is Co-founder and CEO of Leash Bio, which develops AI-driven drug discovery tools combining molecular chemistry with machine learning for pharmaceutical and biotech research.
AB
Andrew BlevinsCTO, Co-founderCo-founder and CTO of Leash Bio, which develops machine learning tools for drug discovery.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingApr 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Leash Bio do?
- Leash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.
- Who founded Leash Bio?
- Leash Bio was founded by Ian Quigley, Andrew Blevins in 2021.
- Who are Leash Bio's investors?
- Leash Bio's investors include Metaplanet, MFV Partners.